These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 31513763)

  • 1. Immunity and vaccine development efforts against Trypanosoma cruzi.
    Rios LE; Vázquez-Chagoyán JC; Pacheco AO; Zago MP; Garg NJ
    Acta Trop; 2019 Dec; 200():105168. PubMed ID: 31513763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine development against Trypanosoma cruzi and Chagas disease.
    Vázquez-Chagoyán JC; Gupta S; Garg NJ
    Adv Parasitol; 2011; 75():121-46. PubMed ID: 21820554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
    Bivona AE; Sánchez Alberti A; Matos MN; Cerny N; Cardoso AC; Morales C; González G; Cazorla SI; Malchiodi EL
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006384. PubMed ID: 29601585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against
    Cerny N; Bivona AE; Sanchez Alberti A; Trinitario SN; Morales C; Cardoso Landaburu A; Cazorla SI; Malchiodi EL
    Front Immunol; 2020; 11():565142. PubMed ID: 33162979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative stress implications for therapeutic vaccine development against Chagas disease.
    Choudhuri S; Rios L; Vázquez-Chagoyán JC; Garg NJ
    Expert Rev Vaccines; 2021 Nov; 20(11):1395-1406. PubMed ID: 34406892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coadministration of cruzipain and GM-CSF DNAs, a new immunotherapeutic vaccine against Trypanosoma cruzi infection.
    Cerny N; Sánchez Alberti A; Bivona AE; De Marzi MC; Frank FM; Cazorla SI; Malchiodi EL
    Hum Vaccin Immunother; 2016; 12(2):438-50. PubMed ID: 26312947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances and challenges towards a vaccine against Chagas disease.
    Quijano-Hernandez I; Dumonteil E
    Hum Vaccin; 2011 Nov; 7(11):1184-91. PubMed ID: 22048121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease.
    Barry MA; Wang Q; Jones KM; Heffernan MJ; Buhaya MH; Beaumier CM; Keegan BP; Zhan B; Dumonteil E; Bottazzi ME; Hotez PJ
    Hum Vaccin Immunother; 2016 Apr; 12(4):976-87. PubMed ID: 26890466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Chagas disease: can prophylaxis and therapeutic vaccines crack this 'hard nut'?
    Bontempi I; Vicco MH; Bayry J
    Immunotherapy; 2016 Feb; 8(2):99-101. PubMed ID: 26787323
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection.
    Garg N; Tarleton RL
    Infect Immun; 2002 Oct; 70(10):5547-55. PubMed ID: 12228281
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Gupta S; Salgado-Jiménez B; Lokugamage N; Vázquez-Chagoyán JC; Garg NJ
    Front Immunol; 2019; 10():1456. PubMed ID: 31293599
    [No Abstract]   [Full Text] [Related]  

  • 12. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
    Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
    J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraflagellar rod proteins administered with alum and IL-12 or recombinant adenovirus expressing IL-12 generates antigen-specific responses and protective immunity in mice against Trypanosoma cruzi.
    Wrightsman RA; Manning JE
    Vaccine; 2000 Jan; 18(14):1419-27. PubMed ID: 10618540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.
    Gupta S; Garg NJ
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e797. PubMed ID: 20706586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Driving of Immune Response by Th1 Adjuvants in Immunization of Mice with Trypanosoma cruzi marinkellei Elicits a Controversial Infection Control.
    Nascentes GA; Hernández CG; Rabelo RA; Coelho RF; Morais FR; Marques T; Batista LR; Meira WS; Oliveira CJ; Lages Silva E; Ramírez LE
    Vector Borne Zoonotic Dis; 2016 May; 16(5):317-25. PubMed ID: 26959861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.
    Sánchez-Valdéz FJ; Pérez Brandán C; Ferreira A; Basombrío MÁ
    Expert Rev Vaccines; 2015 May; 14(5):681-97. PubMed ID: 25496192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice.
    Schnapp AR; Eickhoff CS; Sizemore D; Curtiss R; Hoft DF
    Infect Immun; 2002 Sep; 70(9):5065-74. PubMed ID: 12183554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TcVac1 vaccine delivery by intradermal electroporation enhances vaccine induced immune protection against Trypanosoma cruzi infection in mice.
    Hegazy-Hassan W; Zepeda-Escobar JA; Ochoa-García L; Contreras-Ortíz JME; Tenorio-Borroto E; Barbabosa-Pliego A; Aparicio-Burgos JE; Oros-Pantoja R; Rivas-Santiago B; Díaz-Albiter H; Garg NJ; Vázquez-Chagoyán JC
    Vaccine; 2019 Jan; 37(2):248-257. PubMed ID: 30497833
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Trevisan RO; Santos MM; Desidério CS; Alves LG; de Jesus Sousa T; de Castro Oliveira L; Jaiswal AK; Tiwari S; Bovi WG; de Oliveira-Silva M; Costa-Madeira JC; Castellano LRC; Silva MV; Azevedo V; Rodrigues Junior V; Oliveira CJF; de Castro Soares S
    Dis Markers; 2020; 2020():9130719. PubMed ID: 33488847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type 1 immunity provides optimal protection against both mucosal and systemic Trypanosoma cruzi challenges.
    Hoft DF; Eickhoff CS
    Infect Immun; 2002 Dec; 70(12):6715-25. PubMed ID: 12438346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.